Option chain shows key data for Carter's's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Carter's.

Carter's (NYSE:CRI) Stock, Option Chain

Carter's

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of Carter's sales are in the U.S. and through Carter's brand. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Investire in dividendi: le azioni con i migliori rendimenti del 2024

News

Dividends

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

BLMN

Wall Street&#39;s Most Accurate Analysts Spotlight On 3 Consumer Stocks With Over 5% Dividend Yields

Earnings

Earnings Beats

Mid Cap

Retail Sales

Small Cap

Management

SHOO

Carter&#39;s, Inc. (NYSE: CRI) has been doing well, thanks to its robust business strategies. The company is benefiting from the success of its pricing strategy, inventory-management efforts and better product offerings.

Carter&#39;s Pricing Actions &amp; Wholesale Channel Bode Well

consumers shutter2

Wall Street&#39;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields

Carter's Inc

Churchill Resources Inc

Curis Inc

Exchange Traded Concepts Trust Optica Rare Earths & Critical Materials ETF

CRISPR Therapeutics AG

CRITICAL RES LTD by CRITICAL RES LTD.

Cricut Inc

CRIMSON WINE GROUP LTD by Crimson Wine Group Ltd.

Crimson Wine Group Ltd

Crinetics Pharmaceuticals, Inc. - Common Stock

Crinetics Pharmaceuticals Inc

CRISM THERAPEUTICS CORP by CRISM THERAPEUTICS CORP

Crism Therapeutics Corp

Criteo SA

Critica Ltd

CRITICAL ELEMENTS LITHIUM by Critical Elements Lithium Corporation

Critical Elements Lithium Corp

CRITICAL INFRASTUCTRE TCH by Critical Infrastructure Technologies Ltd.

Critical Infrastructure Technologies Ltd

Critical Metals Corp

CRITICAL METALS PLC by Critical Metals PLC

Critical Metals PLC

CRITICAL ONE ENERGY INC by Critical One Energy Inc.

Critical One Energy Inc

CRITICAL REAGENT PROCESS by Critical Reagent Processing Corp.

Critical Reagent Processing Corp

CRITICAL SOLUTIONS INC by Critical Solutions, Inc.

Critical Solutions Inc

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer discretionary sector.
<h3 class="wp-block-heading">Kohl&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>)</h3>
<ul>
<li>Dividend Yield: 13.14%</li>
<li>Guggenheim analyst Robert Drbul downgraded the stock from Buy to Neutral on Dec. 2. This analyst has an accuracy rate of 67%.</li>
<li>Citigroup analyst Paul Lejuez maintained a Neutral rating and cut the price target from $18 to $14 on Nov. 27. This analyst has an accuracy rate of 64%.</li>
<li>Recent News: On Nov. 26, the company reported a net sales decline of 8.8% year-over-year (Y/Y) to $3.507 billion, missing the consensus of $3.638 billion.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121124&amp;t=be2bearmibe3na1">latest KSS news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="892" height="747" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11075658/image-86.png" alt="" class="wp-image-687329" style="width:614px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11075658/image-86.png 892w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11075658/image-86-300x251.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11075658/image-86-768x643.png 768w" sizes="(max-width: 892px) 100vw, 892px" /></a></figure>
<h3 class="wp-block-heading">Bloomin&#8217; Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>)</h3>
<ul>
<li>Dividend Yield: 7.29%</li>
<li>JP Morgan analyst John Ivankoe maintained a Neutral rating and cut the price target from $19 to $14 on Nov. 12. This analyst has an accuracy rate of 71%.</li>
<li>Raymond James analyst Brian Vaccaro downgraded the stock from Outperform to Market Perform on Nov. 11. This analyst has an accuracy rate of 81%.</li>
<li>Recent News: On Nov. 8, the company reported third-quarter adjusted earnings per share of 21 cents, beating the street view of 20 cents. Quarterly revenues of $1.038 billion (down 3.8%) missed the analyst consensus of $1.042 billion.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121124&amp;t=be2bearmibe3na1">latest BLMN news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="917" height="848" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11075724/image-87.png" alt="" class="wp-image-687330" style="width:657px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11075724/image-87.png 917w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11075724/image-87-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11075724/image-87-768x710.png 768w" sizes="(max-width: 917px) 100vw, 917px" /></a></figure>
<h3 class="wp-block-heading">Carter&#8217;s, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>)</h3>
<ul>
<li>Dividend Yield: 5.83%</li>
<li>Citigroup analyst Paul Lejuez upgraded the stock from Sell to Neutral with a price target of $50 on Nov. 12. This analyst has an accuracy rate of 64%.</li>
<li>Wells Fargo analyst Ike Boruchow maintained an Equal-Weight rating and cut the price target from $72 to $65 on Oct. 28. This analyst has an accuracy rate of 76%.</li>
<li>Recent News: On Oct. 25, Carter&#8217;s issued fourth-quarter adjusted EPS guidance below estimates.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121124&amp;t=be2bearmibe3na1">trend in CRI stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121124&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="926" height="856" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11075801/image-88.png" alt="" class="wp-image-687331" style="width:640px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11075801/image-88.png 926w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11075801/image-88-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11075801/image-88-768x710.png 768w" sizes="(max-width: 926px) 100vw, 926px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/12/42429181/macys-adobe-and-3-stocks-to-watch-heading-into-wednesday">Macy&#8217;s, Adobe And 3 Stocks To Watch Heading Into Wednesday</a></li>
</ul>

Wall Street's Most Accurate Analysts Spotlight On 3 Consumer Stocks With Over 5% Dividend Yields

AMTM

QRVO

WDAY

S&P Dow Jones Indices Announces Changes: Apollo Global Management And Workday To Join S&P 500, Replacing Qorvo And Amentum Holdings; Comerica And Carpenter Technology To Enter S&P MidCap 400, Replacing Vishay Intertechnology And Carters; Vishay And Carters To Move To S&P SmallCap 600, Replacing Comerica And Carpenter Technology

Citigroup analyst Paul Lejuez upgrades Carter's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) from Sell to Neutral and maintains the price target from $50 to $50.

Upgrades

Citigroup Upgrades Carter's to Neutral, Maintains Price Target to $50

Wells Fargo analyst Ike Boruchow maintains Carter's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) with a Equal-Weight and lowers the price target from $72 to $65.

Wells Fargo Maintains Equal-Weight on Carter's, Lowers Price Target to $65

WIIM

Carter's shares are trading lower after the company issued Q4 adjusted EPS guidance below estimates.

Guidance

Carter's Sees Q4 Net Sales Of $800M-$840M Vs. $825.49M Estimate; Projects Adjusted EPS Of $1.32-$1.72 Vs. $1.86 Estimate

Carter's Raises FY24 Adjusted EPS Outlook To $4.70 to $5.15 Vs. $5.04 Estimate (Previous Guidance: $4.60-$5.05); Reaffirms Net Sales View Of $2.785B-$2.825B Vs. $2.807B Estimate

Carter's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) reported quarterly earnings of $1.64 per share which beat the analyst consensus estimate of $1.40 by 17.14 percent. This is a 10.87 percent decrease over earnings of $1.84 per share from the same period last year. The company reported quarterly sales of $758.46 million which beat the analyst consensus estimate of $755.61 million by 0.38 percent. This is a 4.19 percent decrease over sales of $791.65 million the same period last year.

Carter's Q3 Adj $1.64 Beats $1.39 Estimate, Sales $758.46M Beat $755.61M Estimate

Carter's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) is preparing to release its quarterly earnings on Friday, 2024-10-25. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Carter's to report an earnings per share (EPS) of $1.34.
The market awaits Carter's's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings History Snapshot</h3>
In the previous earnings release, the company beat EPS by $0.27, leading to a 0.0% drop in the share price the following trading session.
Here's a look at Carter's's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.49</td>
<td>0.77</td>
<td>2.63</td>
<td>1.54</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.76</td>
<td>1.04</td>
<td>2.76</td>
<td>1.84</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.0%</td>
<td>-2.0%</td>
<td>2.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729782059_0_0.png" alt="eps graph" />
<h3>Tracking Carter's's Stock Performance</h3>
Shares of Carter's were trading at $65.55 as of October 23. Over the last 52-week period, shares are up 2.53%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analysts' Take on Carter's</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Carter's.
Analysts have provided Carter's with 2 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $63.0, suggesting a potential 3.89% downside.
<h3>Analyzing Ratings Among Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of Hanesbrands, G-III Apparel Group and Oxford Industries, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>For Hanesbrands, analysts project an Neutral trajectory, with an average 1-year price target of $6.17, indicating a potential 90.59% downside.</li>
<li>G-III Apparel Group received a Neutral consensus from analysts, with an average 1-year price target of $31.6, implying a potential 51.79% downside.</li>
<li>The consensus outlook from analysts is an Neutral trajectory for Oxford Industries, with an average 1-year price target of $88.0, indicating a potential 34.25% upside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
In the peer analysis summary, key metrics for Hanesbrands, G-III Apparel Group and Oxford Industries are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Carter's</td>
<td>Neutral</td>
<td>-5.96%</td>
<td>$282.94M</td>
<td>3.28%</td>
</tr>
<tr>
<td>Hanesbrands</td>
<td>Neutral</td>
<td>-3.83%</td>
<td>$307.07M</td>
<td>-148.24%</td>
</tr>
<tr>
<td>G-III Apparel Group</td>
<td>Neutral</td>
<td>-2.27%</td>
<td>$275.87M</td>
<td>1.60%</td>
</tr>
<tr>
<td>Oxford Industries</td>
<td>Neutral</td>
<td>-0.10%</td>
<td>$265.01M</td>
<td>6.69%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Carter's ranks at the top for Gross Profit and Return on Equity among its peers. However, it ranks at the bottom for Revenue Growth.
<h3>About Carter's</h3>
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of Carter's sales are in the U.S. and through Carter's brand. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.
<h3>Financial Milestones: Carter's's Journey</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Carter's faced challenges, resulting in a decline of approximately -5.96% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 4.8%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Carter's's ROE excels beyond industry benchmarks, reaching 3.28%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.17%, the company showcases effective utilization of assets.
Debt Management: Carter's's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.31.
<a href="https://www.benzinga.com/quote/CRI/earnings">To track all earnings releases for Carter's visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview: Carter's

BURL

FORD

PLCE

ROST

SCVL

ULTA

Shares of apparel-related stocks are trading lower possibly amid overall market weakness. Also, the sector could be pulling back from Friday's rally after the dockworkers reached a tentative deal to suspend their strike.

Wells Fargo analyst Ike Boruchow maintains Carter's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) with a Equal-Weight and raises the price target from $60 to $72.

Wells Fargo Maintains Equal-Weight on Carter's, Raises Price Target to $72

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/06/24</td>
<td>$175.00</td>
<td>$37.9K</td>
<td>2.5K</td>
<td>7.9K</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/06/24</td>
<td>$207.50</td>
<td>$32.9K</td>
<td>921</td>
<td>6.1K</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/30/24</td>
<td>$85.00</td>
<td>$27.2K</td>
<td>2.4K</td>
<td>3.6K</td>
</tr>
<tr>
<td>LCID</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$4.00</td>
<td>$57.0K</td>
<td>10.1K</td>
<td>3.1K</td>
</tr>
<tr>
<td>FIVE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$85.00</td>
<td>$27.8K</td>
<td>3.4K</td>
<td>1.8K</td>
</tr>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/30/24</td>
<td>$96.00</td>
<td>$46.3K</td>
<td>0</td>
<td>1.7K</td>
</tr>
<tr>
<td>HAS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$67.50</td>
<td>$40.4K</td>
<td>193</td>
<td>734</td>
</tr>
<tr>
<td>CRI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/20/24</td>
<td>$70.00</td>
<td>$45.9K</td>
<td>1.2K</td>
<td>620</td>
</tr>
<tr>
<td>HD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$390.00</td>
<td>$118.2K</td>
<td>569</td>
<td>566</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$60.00</td>
<td>$36.0K</td>
<td>19.9K</td>
<td>535</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we observe a call option trade with bullish sentiment. It expires in 10 day(s) on September 6, 2024. Parties traded 150 contract(s) at a $175.00 strike. The total cost received by the writing party (or parties) was $37.9K, with a price of $253.0 per contract. There were 2580 open contracts at this strike prior to today, and today 7984 contract(s) were bought and sold. 
• For TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we notice a put option trade that happens to be neutral, expiring in 10 day(s) on September 6, 2024. This event was a transfer of 61 contract(s) at a $207.50 strike. The total cost received by the writing party (or parties) was $32.9K, with a price of $540.0 per contract. There were 921 open contracts at this strike prior to today, and today 6101 contract(s) were bought and sold. 
• Regarding NKE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), we observe a call option trade with bullish sentiment. It expires in 3 day(s) on August 30, 2024. Parties traded 250 contract(s) at a $85.00 strike. The total cost received by the writing party (or parties) was $27.2K, with a price of $109.0 per contract. There were 2454 open contracts at this strike prior to today, and today 3643 contract(s) were bought and sold. 
• Regarding LCID (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>), we observe a call option sweep with bullish sentiment. It expires in 24 day(s) on September 20, 2024. Parties traded 1500 contract(s) at a $4.00 strike. This particular call needed to be split into 13 different trades to become filled. The total cost received by the writing party (or parties) was $57.0K, with a price of $38.0 per contract. There were 10144 open contracts at this strike prior to today, and today 3139 contract(s) were bought and sold. 
• For FIVE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>), we notice a call option sweep that happens to be bullish, expiring in 24 day(s) on September 20, 2024. This event was a transfer of 53 contract(s) at a $85.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $27.8K, with a price of $519.0 per contract. There were 3456 open contracts at this strike prior to today, and today 1825 contract(s) were bought and sold. 
• For PDD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), we notice a call option sweep that happens to be bearish, expiring in 3 day(s) on August 30, 2024. This event was a transfer of 200 contract(s) at a $96.00 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $46.3K, with a price of $232.0 per contract. There were 0 open contracts at this strike prior to today, and today 1784 contract(s) were bought and sold. 
• For HAS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>), we notice a put option sweep that happens to be bearish, expiring in 143 day(s) on January 17, 2025. This event was a transfer of 86 contract(s) at a $67.50 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $40.4K, with a price of $470.0 per contract. There were 193 open contracts at this strike prior to today, and today 734 contract(s) were bought and sold. 
• For CRI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>), we notice a put option sweep that happens to be neutral, expiring in 24 day(s) on September 20, 2024. This event was a transfer of 200 contract(s) at a $70.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $45.9K, with a price of $230.0 per contract. There were 1269 open contracts at this strike prior to today, and today 620 contract(s) were bought and sold. 
• For HD (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>), we notice a call option trade that happens to be bullish, expiring in 52 day(s) on October 18, 2024. This event was a transfer of 275 contract(s) at a $390.00 strike. The total cost received by the writing party (or parties) was $118.2K, with a price of $430.0 per contract. There were 569 open contracts at this strike prior to today, and today 566 contract(s) were bought and sold. 
• For CMG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), we notice a call option sweep that happens to be bullish, expiring in 143 day(s) on January 17, 2025. This event was a transfer of 100 contract(s) at a $60.00 strike. This particular call needed to be split into 13 different trades to become filled. The total cost received by the writing party (or parties) was $36.0K, with a price of $360.0 per contract. There were 19925 open contracts at this strike prior to today, and today 535 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AMZN

FIVE

LCID

Citigourp Global Markets 2% Protected Notes Linked To The Djia

TSLA

10 Consumer Discretionary Stocks Whale Activity In Today's Session

Carter&#39;s, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cri#NYSE">CRI</a>) has been doing well, thanks to its robust business strategies. The company is benefiting from the success of its pricing strategy, inventory-management efforts and better product offerings. Management is focused on creating a trend-right merchandise assortment, deepening relations with customers via marketing, expanding international markets and efficiently controlling expenses.
<h3>Delving Deeper</h3>
Carter&#39;s has made significant pricing actions to address market conditions and enhance profitability. In second-quarter 2024, the company saw improved price realization and profit margins, thanks to the strength in its product offerings and lower inbound freight rates, along with better inventory management.
We note that the company is focused on essential core products. This focus, coupled with a compelling value proposition, wherein average retail price points are around $11, makes Carter&#39;s an attractive option for budget-conscious consumers. Its pricing strategy involves keeping its brands competitively priced, which has proven effective in maintaining competitiveness in the market.
The company&#39;s new Oshkosh back-to-school launch, the premium fashion denim and bottoms, has received positive feedback from customers. Also, Little Planet and PurelySoft, its newest and sustainable brands, have been performing well. Management expects about $50 million with respect to the incremental investments in pricing and marketing in the second half of 2024. The impact of this price adjustment will be around $40 million on its annual operating income.
Although Carter&#39;s top line continued to witness the impacts of inflation on reduced consumer spending, the demand trends in the wholesale segment showed improvement in the second quarter. The company noted that its wholesale segment is gaining from leaner inventories with wholesale customers.
As a result, CRI registered growth in its U.S. Wholesale sales. In the reported quarter, it saw higher demand in its U.S. Wholesale segment, led by the exclusive brands. It experienced double-digit growth in the replenishment wholesale sales in the quarter. The company&#39;s supply chain continues to strengthen the business, offsetting lower product costs for the rest of this year. For the U.S. Wholesale business, management projects strong growth in 2024.
Carter&#39;s, which shares space with Wolverine (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/www#NYSE">WWW</a>), Skechers (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/skx#NYSE">SKX</a>) and Steven Madden (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shoo#NASDAQ">SHOO</a>), focuses on efficient cost management and operational improvements. The company has been witnessing a notable expansion in its margin rates, driven in part by lower inbound freight rates, which were the significant contributor to the margins. In the second quarter, the gross margin expanded 150 basis points (bps) on lower product input costs, a decline in inbound freight rates and soft sales to the off-price channel, which were partly offset by inventory provisions. The adjusted operating margin increased 70 bps to 7%.
Margins have been driving the bottom line as well. In the second quarter, Carter&#39;s reported adjusted earnings of 76 cents per share, which surpassed the Zacks Consensus Estimate of 45 cents. The figure rose 18.8% from earnings of 64 cents per share in the prior-year quarter.
For the rest of 2024, Carter&#39;s anticipates lower product costs, which are expected to enable it to strengthen its product offerings and sharpen price points, thereby improving profitability. It anticipates inbound freight costs down more than 20%.
<h3>Other Stocks</h3>
Wolverine has been making significant strides in its transformation plan. The company is enhancing its consumer engagement with innovative marketing campaigns and strengthening its global presence. Its strategic initiatives emphasize consumer-centricity, with investments in talent acquisition, consumer insights and innovation. This approach enhances brand loyalty, fosters product innovation and drives long-term growth by meeting evolving consumer demands.&nbsp; With a consistent focus on product innovation and market positioning, Wolverine is well-positioned for continued growth and increased market share.
Skechers&#39; diversified portfolio of footwear, focusing on comfort-based products and leveraging a multi-brand strategy, is proving successful. The company is investing in global infrastructure, including retail stores, e-commerce platforms and distribution centers. It continues to expand its direct-to-consumer segment and bolsterinternational sales growth. Additionally, the company plans to open new stores, thereby enhancing its omnichannel capabilities. Its top line jumped 7.2% year over year, backed by a 6.9% rise in international sales and a 7.7% increase in domestic sales in second-quarter 2024.
Steven Madden&#39;s solid performance across its wholesale, direct-to-consumer and licensing segments highlights the execution of its robust strategic initiatives and positions it well for growth. The company is focused on leveraging digital capabilities, expanding categories beyond footwear, such as handbags and apparel, and enhancing its international market presence. In the second quarter, Steven Madden&#39;s revenues increased 17.6% year over year, with Wholesale revenues growing 22.5% and DTC revenues rising 6.4%.
<a href="https://www.zacks.com/stock/news/2322687/carter-s-cri-pricing-actions-wholesale-channel-bode-well?cid=CS-BENZ-FT-analyst_blog|zer_report_update-2322687">To read this article on Zacks.com click here.</a>

Carter's Pricing Actions & Wholesale Channel Bode Well

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments">high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer discretionary sector.
<h3 class="wp-block-heading">Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>)</h3>
<ul>
<li>Dividend Yield: 6.13%</li>
<li>Goldman Sachs analyst Mark Delaney maintained a Neutral rating and cut the price target from $14 to $12 on July 25. This analyst has an accuracy rate of 76%.</li>
<li>Piper Sandler analyst Alexander Potter initiated coverage on the stock with a Neutral rating and a price target of $13 on March 15. This analyst has an accuracy rate of 77%.</li>
<li>Recent News: On Aug. 2, Ford Motor said it sold 31% more EVs in the U.S. last month than last year, thanks to the rising popularity of its EV pickup truck.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080724&amp;t=be2bearmibe3na1">alerted to latest Ford news.</a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="916" height="831" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051253/image-1-13.png" alt="" class="wp-image-481013" style="width:485px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051253/image-1-13.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051253/image-1-13-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051253/image-1-13-768x697.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure>
<h3 class="wp-block-heading">Carter&#8217;s, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>)</h3>
<ul>
<li>Dividend Yield: 5.21%</li>
<li>Wells Fargo analyst Ike Boruchow maintained an Equal-Weight rating and lowered the price target from $75 to $68 on April 24. This analyst has an accuracy rate of 72%.</li>
<li>UBS analyst Jay Sole maintained a Neutral rating and raised the price target from $76 to $79 on Feb. 28. This analyst has an accuracy rate of 72%.</li>
<li>Recent News: On July 26, Carter&#8217;s issued weak guidance.</li>
<li>Benzinga Pro&#8217;s charting tool helped i<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080724&amp;t=be2bearmibe3na1">dentify the trend in CRI's stock</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="911" height="831" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051347/image-29.png" alt="" class="wp-image-481017" style="width:506px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051347/image-29.png 911w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051347/image-29-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051347/image-29-768x701.png 768w" sizes="(max-width: 911px) 100vw, 911px" /></a></figure>
<h3 class="wp-block-heading">The Aaron&#8217;s Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>)</h3>
<ul>
<li>Dividend Yield: 4.98%</li>
<li>Truist Securities analyst Scot Ciccarelli maintained a Hold rating and raised the price target from $8 to $10.1 on June 18. This analyst has an accuracy rate of 72%.</li>
<li>TD Cowen analyst Hoang Nguyen maintained a Hold rating and raised the price target of $8 to $10.1 on June 17. This analyst has an accuracy rate of 71%.</li>
<li>Recent News: On Aug. 5, Aaron&#8217;s posted weaker-than-expected quarterly results.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080724&amp;t=be2bearmibe3na1">breakout in AAN shares</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="881" height="835" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051432/image-30.png" alt="" class="wp-image-481019" style="width:509px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051432/image-30.png 881w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051432/image-30-300x284.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/07051432/image-30-768x728.png 768w" sizes="(max-width: 881px) 100vw, 881px" /></a></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40194186/top-4-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 4 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>

Wall Street's Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields

B of A Securities analyst Christopher Nardone maintains Carter's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) with a Underperform and lowers the price target from $65 to $54.

B of A Securities Maintains Underperform on Carter's, Lowers Price Target to $54

Shares of Saia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) fell sharply during Friday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/SAIA/earnings">second-quarter financial results</a>.
Saia reported quarterly earnings of $3.83 per share which missed the analyst consensus estimate of $4.00 per share. The company reported quarterly sales of $823.24 million which missed the analyst consensus estimate of $826.55 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Saia shares dipped 18.6% to $398.01 on Friday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) gained 117.4% to $0.4639 after the company announced it reached a legal settlement agreement with Lion Point Capital. The company agreed to pay $1,350,000 and issue Lion Point 300,000 of preferred stock.</li>
<li>Windtree Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares jumped 101.3% to $6.67 after the company filed a request for the withdrawal of its registration statement on a Form S-1.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) gained 53% to $13.94.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares gained 46.2% to $10.83 after the company beat second-quarter earnings estimates.</li>
<li>Carbon Revolution Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREV#NASDAQ">CREV</a>) shares climbed 43.3% to $8.84. Carbon Revolution said it will supply the carbon fiber wheels available on the just-revealed Chevrolet Corvette ZR1.</li>
<li>Everi Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVRI#NYSE">EVRI</a>) rose 41.1% to $12.93 after it entered an agreement to be acquired by funds managed by Apollo affiliates for $14.25 per share in cash.</li>
<li>Nauticus Robotics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) gained 37% to $4.45.</li>
<li>Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) jumped 36.6% to $8.66 on better-than-expected second-quarter earnings and raising FY24 outlook.</li>
<li>Sangamo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) gained 35% to $0.9043.</li>
<li>CEL-SCI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) rose 28% to $1.55 after the company announced results from a bias analysis conducted for its concluded Phase 3 study of Multikine. Multikine cut the 5-year risk of death by half compared to control in its target population.</li>
<li>AudioEye, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) rose 25% to $24.52 following second-quarter results.</li>
<li>Pineapple Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAPL#NYSE">PAPL</a>) gained 24.4% to $1.1760. Pineapple Financial CSO Christa Lillian Mitchell bought a total of 2,000 shares at an average price of $0.88.</li>
<li>Douglas Elliman Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOUG#NYSE">DOUG</a>) climbed 23% to $1.66.</li>
<li>CareMax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) rose 19% to $6.71.</li>
<li>Liberty Broadband Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBRDA#NASDAQ">LBRDA</a>) rose 17.6% to $65.16.</li>
<li>Charter Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) jumped 17% to $368.65 after the company reported better-than-expected second-quarter financial results.</li>
<li>Mohawk Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) gained 16.5% to $156.70 following mixed second-quarter earnings.</li>
<li>Karooooo Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) gained 16% to $33.40. Karooooo announced termination of secondary public offering of ordinary shares due to market conditions.</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) climbed 15% to $118.99 after better-than-expected second-quarter financial results and FY24 EPS outlook raise.</li>
<li>International Game Technology PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGT#NYSE">IGT</a>) gained 13.4% to $22.86 after the company entered an agreement for its Gaming &amp; Digital business to be acquired by funds managed by affiliates of Apollo.</li>
<li>Altice USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATUS#NYSE">ATUS</a>) rose 12.1% to $1.76.</li>
<li>Stardust Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) rose 11% to $15.06.</li>
<li>Avantor, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) surged 11% to $25.32 after the company reported better-than-expected second-quarter earnings results.</li>
<li>Norfolk Southern Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) gained 10.7% to $246.86 after the company reported better-than-expected second-quarter earnings results.</li>
<li>Selina Hospitality PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) shares gained 10.4% to $0.0415 after falling over 17% on Thursday.</li>
<li>Viasat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) rose 9% to $20.58. Viasat announced new reporting segment structure.</li>
<li>Deckers Outdoor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) shares gained 8.7% to $914.71 as the company reported better-than-expected results for the first quarter. The company said it still expects net sales to increase approximately 10% year-over-year in fiscal year 2025 to $4.7 billion.</li>
<li>Bristol-Myers Squibb Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) climbed 7.6% to $48.69 following strong second-quarter earnings and increased 2024 guidance.</li>
<li>Centene Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) climbed 7.6% to $72.55 following better-than-expected second-quarter financial results and increased 2024 guidance.</li>
<li>Columbia Banking System, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLB#NASDAQ">COLB</a>) rose 7.4% to $25.98 after the company reported better-than-expected quarterly earnings results. Also, multiple firms raised their respective price targets on its stock.</li>
<li>Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) gained 6.8% to $319.30 after the company reported better-than-expected quarterly revenue results.</li>
<li>Ultra Clean Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) shares gained 4.7% to $47.26 following better-than-expected quarterly results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>NovaBay Pharmaceuticals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) shares dipped 59.6% to $0.7830 after the company reported pricing of $3.5 million underwritten public offering.</li>
<li>Tantech Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TANH#NASDAQ">TANH</a>) fell 46.9% to $0.2603.</li>
<li>Nature&#8217;s Miracle Holding Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) fell 46.4% to $0.2099 after the company announced pricing of $1.2 million public offering.</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) shares declined 40.7% to $63.97 after the company reported worse-than-expected second-quarter revenue results and issued weak FY24 revenue guidance.</li>
<li>Predictive Oncology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POAI#NASDAQ">POAI</a>) fell 29.6% to $1.3150. Predictive Oncology announced exercise of warrants for $1.26 million gross proceeds.</li>
<li>ProMIS Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMN#NASDAQ">PMN</a>) declined 29.2% to $1.5006 as the company reported top-line data from its Phase 1a Alzheimer&#8217;s trial and announced up to $122.7 million private placement financing.</li>
<li>PS International Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIG#NASDAQ">PSIG</a>) dipped 26.1% to $1.53</li>
<li>Grom Social Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GROM#NASDAQ">GROM</a>) fell 23.8% to $0.2751.</li>
<li>Ocean Power Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#NASDAQ">OPTT</a>) shares declined 23.2% to $0.3188 after reporting fourth-quarter results.</li>
<li>Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) fell 20.2% to $1.30.</li>
<li>Next Technology Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) declined 20.1% to $1.6299.</li>
<li>Zynex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) shares fell 18.9% to $8.27 after the company reported worse-than-expected second-quarter financial results.</li>
<li>2U, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWOU#NASDAQ">TWOU</a>) declined 17.6% to $1.24.</li>
<li>Ur-Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URG#NYSE">URG</a>) shares dipped 13.4% to $1.1250 after the company announced a proposed public offering of common shares.</li>
<li>BJ&#8217;s Restaurants, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJRI#NASDAQ">BJRI</a>) fell 12.6% to $32.53 following quarterly results.</li>
<li>Booz Allen Hamilton Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) declined 11.8% to $135.36 following a first-quarter earnings miss and soft EPS guidance.</li>
<li>Advent Technologies Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADN#NASDAQ">ADN</a>) shares fell 11.2% to $4.40 after gaining 3% on Thursday.</li>
<li>Tarsus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) fell 9.1% to $25.67.</li>
<li>World Acceptance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) dipped 7.8% to $134.62 following weak quarterly sales.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) fell 7.4% to $25.61.</li>
<li>Olin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) shares declined 7.2% to $44.56 following a second-quarter earnings miss.</li>
<li>Carter&#8217;s, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) shares fell 6.6% to $55.87 following weak quarterly sales.</li>
<li>Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) declined 6.3% to $213.01 after the European Medicines Agency adopted a negative opinion on the Marketing Authorization Approval for lecanemab.</li>
<li>Tandem Diabetes Care, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) shares fell 6% to $38.18. Tandem Diabetes Care will release its second quarter results after the closing bell on Thursday, Aug. 1.</li>
<li>L3Harris Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) declined 4.6% to $232.05 following second-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39984491/nvidia-lockheed-martin-and-2-other-stocks-insiders-are-selling">Nvidia, Lockheed Martin And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

Intraday Update

Movers

AEYE

ATUS

AVGR

AVTR

BIIB

BJRI

CHTR

CMAX

COLB

COUR

CREV

DECK

DOUG

DXCM

EVRI

FWRD

GROM

KARO

KITT

LBRDA

NMHI

Next Technology Holding Inc. - Ordinary Shares

NXTT

OPTT

PAPL

POAI

PSIG

SAIA

SDST

SGMO

SLNA

TANH

TARS

TNDM

TWOU

UCTT

VSAT

WINT

WRLD

ZYXI

Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session

Carter's shares are trading lower after the company issued weak guidance.

U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Friday.
Shares of DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) fell sharply during Friday's pre-market trading after the company reported worse-than-expected second-quarter revenue results and issued <a href="https://www.benzinga.com/news/earnings/24/07/39971462/dexcom-stock-drops-after-mixed-q2-results-weak-forward-guidance">weak FY24 revenue guidance</a>.
DexCom reported quarterly earnings of 43 cents per share, which beat the analyst consensus estimate of 39 cents. Quarterly sales came in at $1.004 billion which missed the analyst consensus estimate of $1.036 billion.
DexCom sees third-quarter revenue in a range of $975 million to $1 billion, versus the $1.15 billion estimate, and full-year revenue in a range of $4. billion to $4.05 billion, versus the $4.33 billion estimate.
DexCom shares dipped 37% to $68.00 in the pre-market trading session.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Zynex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) shares declined 21.5% to $8.00 in pre-market trading after the company reported worse-than-expected second-quarter financial results.</li>
<li>Ur-Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URG#NYSE">URG</a>) shares fell 9.2% to $1.18 in pre-market trading after the company announced a proposed public offering of common shares.</li>
<li>Tandem Diabetes Care, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) shares declined 9% to $36.99 in pre-market trading. Tandem Diabetes Care will release its second quarter results after the closing bell on Thursday, Aug. 1.</li>
<li>MacroGenics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) shares dipped 8.9% to $5.01 in pre-market trading after gaining 5% on Thursday.</li>
<li>Olin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) shares declined 8.1% to $44.15 in pre-market trading following a second-quarter earnings miss.</li>
<li>Carter&#8217;s, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRI#NYSE">CRI</a>) shares fell 7.4% to $55.40 in pre-market trading following weak quarterly sales.</li>
<li>Indivior PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDV#NASDAQ">INDV</a>) shares fell 4.4% to $12.52 in pre-market trading. Indivior shares jumped 20% on Thursday after the company reported better-than-expected second-quarter financial results and announced an accelerated $100 million share repurchase program.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39978094/s-p-500-nasdaq-settle-lower-as-tech-stocks-continue-to-falter-greed-index-in-fear-zone">S&amp;P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In &#8216;Fear&#8217; Zone</a></li>
</ul>

INDV

MGNX

DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Carter's Sees Q3 Sales Of $735M - $755M Vs. $805.92M Est; Adj EPS Of $1.10 - $1.35 Vs. $1.88 Est.

Carter's Sees FY24 Sales Of $2.785B -$2.825B Vs. $2.92B Est; Adj EPS Of $4.60 - $5.05 Vs. $6.2 Est.

Press Releases

Carter's, Inc. to Report Second Quarter Fiscal 2024 Results on Friday, July 26, 2024

Carter's, Inc. Reports Second Quarter Fiscal 2024 Results

Carter's, Inc. Announces Quarterly Dividend

Carter's, Inc. Announces Participation at the Goldman Sachs 31st Annual Global Retailing Conference

Carter's, Inc. to Report Third Quarter Fiscal 2024 Results on Friday, October 25, 2024

Carter's, Inc. Reports Third Quarter Fiscal 2024 Results

Carter's Teams up With Chloe Bailey to Introduce a New Era of Holiday Cheer

Apollo Global Management and Workday Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Comments

Carter's

Carter's (CRI) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga